Helex to present its latest progress on a gene editing-based therapeutic for PKD1-driven ADPKD at the ESGCT Annual Meeting, Seville, Spain on October 8, 2025
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.